Current Drug Targets

Editor-in-Chief:

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Become EABM
Become Reviewer

Preface [Hot Topic: Cellular Targets for Anti-Cancer Therapy (Guest Editor: Alexander A. Shtil)] promotion: free to download

Volume:5   Issue: 4
Pp: i-i
Alexander A. Shtil
DOI: 10.2174/1389450043345506

Cellular Targets for Anticancer Strategies

Volume:5   Issue: 4
Pp: 347-355
Caterina A.M. La Porta
DOI: 10.2174/1389450043345434

DNA-Binding Properties of Poly(ADP-Ribose) Polymerase: A Target for Anti-Cancer Therapy

Volume:5   Issue: 4
Pp: 357-365
V. A. Soldatenkov and V. N. Potaman
DOI: 10.2174/1389450043345498

CARD Proteins as Therapeutic Targets in Cancer

Volume:5   Issue: 4
Pp: 367-374
Jason S. Damiano and John C. Reed
DOI: 10.2174/1389450043345470

Sphingolipid Metabolism Enzymes as Targets for Anti-Cancer Therapy

Volume:5   Issue: 4
Pp: 375-382
J. W. Kok and H. Sietsma
DOI: 10.2174/1389450043345452

Potential for Predicting Toxicity and Response of Fluoropyrimidines in Patients

Volume:5   Issue: 4
Pp: 383-388
James F. Eliason and Attila Megyeri
DOI: 10.2174/1389450043345461

Molecular Targeting of Drug Delivery Systems to Cancer

Volume:5   Issue: 4
Pp: 389-406
T. Minko, S. S. Dharap, R. I. Pakunlu and Y. Wang
DOI: 10.2174/1389450043345443